Loading clinical trials...
Loading clinical trials...
Addictions Neuroclinical Assessment
Background: Alcohol use disorder (AUD) is a major public health problem. In the U.S., 16 to 18 million adults have an AUD. Researchers want to test an assessment tool called the ANA. It uses self-report and behavioral measures to assess 3 neuroscience domains of addiction. They hope to better understand, manage, prevent, and treat AUD. Objective: To learn how people s brains function related to their drinking. Eligibility: People ages 18 years and older who have enrolled in NIAAA natural history study 14-AA-0181. Design: Participants will complete surveys and tasks on a computer. The surveys and tasks assess a range of aspects of thinking and making decisions. The surveys and tasks also assess behaviors and feelings about alcohol and other rewards, and negative emotions. Participants will spend 90 minutes on the computer. Then they will take a break. In total, they will spend 4 blocks of time on the computer. Each block will last 90 minutes. They will take a break in between each block of time. They can take more breaks if needed. Outpatient participants and healthy volunteers will complete this study in 1 visit. It will last about 6 hours. A second visit may be scheduled if needed. Outpatient participants will take a breath alcohol test. If their test is positive, their visit may be rescheduled or they may be withdrawn from the study. Inpatient participants will complete this study over several days. Data collected from participants in this study may be combined and analyzed with their data from NIAAA study 14-AA-0181 and/or NIAAA imaging study 14-AA-0080.
Study Description: This is a protocol examining a battery of assessments designed to study three neurofunctional domains relevant to alcohol use disorder (AUD), negative emotionality, incentive salience and executive function. The study will examine the relationships among the three ANA domains with the goal of identifying sub-types of AUD based on variation in the ANA domains. Objectives: Primary Objectives: 1. To examine the relationship between the three ANA domains (i.e. Negative Emotionality, Incentive Salience, Executive Function). 2. To identify the different subtypes of AUD based on variation in the ANA domains. Secondary Objectives: None Endpoints: Primary Endpoint: Latent factors of each of the ANA domains: * Negative emotionality * Incentive Salience * Executive Function Secondary Endpoints: None
Age
18 - 99 years
Sex
ALL
Healthy Volunteers
Yes
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Start Date
August 12, 2021
Primary Completion Date
December 31, 2031
Completion Date
December 31, 2031
Last Updated
February 19, 2026
1,400
ESTIMATED participants
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NCT05855668
NCT06561828
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07071779